Demand for interim executive leadership is accelerating across Life Sciences and Healthcare. Companies facing regulatory complexity, financing pressure, rapid growth, and leadership gaps are increasingly turning to interim and fractional executives to maintain momentum without waiting months for a permanent hire.

Leadership gaps don't wait for a permanent search to finish. As Life Sciences and Healthcare companies navigate product launches, financing events, acquisitions, and executive departures, interim and fractional executives are helping organizations maintain momentum and reduce risk. The companies moving fastest are separating urgent leadership needs from permanent hiring decisions.

Getting acquired resets everything—titles, influence, and expectations. This article breaks down what determines who succeeds in the first 90 days post-acquisition, and why visibility, alignment, and adaptability matter more than past performance. A practical guide for leaders navigating M&A in healthcare and life sciences.

M&A activity is accelerating again across healthcare and life sciences. But while deals are modeled around strategy and financials, most fail at culture integration. This article breaks down why leadership alignment, culture, and execution—not the deal itself—determine success.

Demand for interim executive leadership is accelerating across Life Sciences and Healthcare. Companies facing regulatory complexity, financing pressure, rapid growth, and leadership gaps are increasingly turning to interim and fractional executives to maintain momentum without waiting months for a permanent hire.

Leadership gaps don't wait for a permanent search to finish. As Life Sciences and Healthcare companies navigate product launches, financing events, acquisitions, and executive departures, interim and fractional executives are helping organizations maintain momentum and reduce risk. The companies moving fastest are separating urgent leadership needs from permanent hiring decisions.

Getting acquired resets everything—titles, influence, and expectations. This article breaks down what determines who succeeds in the first 90 days post-acquisition, and why visibility, alignment, and adaptability matter more than past performance. A practical guide for leaders navigating M&A in healthcare and life sciences.

M&A activity is accelerating again across healthcare and life sciences. But while deals are modeled around strategy and financials, most fail at culture integration. This article breaks down why leadership alignment, culture, and execution—not the deal itself—determine success.